Literature DB >> 35221848

Primary and Secondary Prevention of CAD: A Review.

Lindsay Short1,2, Van T La1,2, Mandira Patel1,2, Ramdas G Pai1,2.   

Abstract

Coronary artery disease is the leading cause of death in both men and women, yet adequate control of risk factors can largely reduce the incidence and recurrence of cardiac events. In this review, we discuss various life style and pharmacological measures for both the primary and secondary prevention of coronary artery disease. With a clear understanding of management options, health care providers have an excellent opportunity to educate patients and ameliorate a significant burden of morbidity and mortality. International College of Angiology. This article is published by Thieme.

Entities:  

Keywords:  aspirin; atherosclerosis; coronary artery; hypercholesterolemia; hypertension; myocardial infarction; prevention

Year:  2021        PMID： 35221848      PMCID： PMC8881111          DOI： 10.1055/s-0041-1729925

Source DB:  PubMed          Journal:  Int J Angiol        ISSN： 1061-1711


  76 in total

1.  Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.

Authors:  Clive Rosendorff; Henry R Black; Christopher P Cannon; Bernard J Gersh; Joel Gore; Joseph L Izzo; Norman M Kaplan; Christopher M O'Connor; Patrick T O'Gara; Suzanne Oparil
Journal:  Circulation       Date:  2007-05-14       Impact factor: 29.690

2.  Effects of Tobacco Smoking on Cardiovascular Disease.

Authors:  Takahisa Kondo; Yoshihisa Nakano; Shiro Adachi; Toyoaki Murohara
Journal:  Circ J       Date:  2019-08-29       Impact factor: 2.993

3.  Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo.

Authors:  C Cade; A W Norman
Journal:  Endocrinology       Date:  1986-07       Impact factor: 4.736

4.  Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

Authors:  Paul M Ridker; Julie E Buring; Nader Rifai; Nancy R Cook
Journal:  JAMA       Date:  2007-02-14       Impact factor: 56.272

5.  Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.

Authors:  Louise Bowman; Marion Mafham; Karl Wallendszus; Will Stevens; Georgina Buck; Jill Barton; Kevin Murphy; Theingi Aung; Richard Haynes; Jolyon Cox; Aleksandra Murawska; Allen Young; Michael Lay; Fang Chen; Emily Sammons; Emma Waters; Amanda Adler; Jonathan Bodansky; Andrew Farmer; Roger McPherson; Andrew Neil; David Simpson; Richard Peto; Colin Baigent; Rory Collins; Sarah Parish; Jane Armitage
Journal:  N Engl J Med       Date:  2018-08-26       Impact factor: 91.245

6.  Southern Dietary Pattern is Associated With Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  James M Shikany; Monika M Safford; P K Newby; Raegan W Durant; Todd M Brown; Suzanne E Judd
Journal:  Circulation       Date:  2015-08-10       Impact factor: 29.690

7.  Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.

Authors:  John J McNeil; Rory Wolfe; Robyn L Woods; Andrew M Tonkin; Geoffrey A Donnan; Mark R Nelson; Christopher M Reid; Jessica E Lockery; Brenda Kirpach; Elsdon Storey; Raj C Shah; Jeff D Williamson; Karen L Margolis; Michael E Ernst; Walter P Abhayaratna; Nigel Stocks; Sharyn M Fitzgerald; Suzanne G Orchard; Ruth E Trevaks; Lawrence J Beilin; Colin I Johnston; Joanne Ryan; Barbara Radziszewska; Michael Jelinek; Mobin Malik; Charles B Eaton; Donna Brauer; Geoff Cloud; Erica M Wood; Suzanne E Mahady; Suzanne Satterfield; Richard Grimm; Anne M Murray
Journal:  N Engl J Med       Date:  2018-09-16       Impact factor: 91.245

8.  The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

Authors:  Jill Belch; Angus MacCuish; Iain Campbell; Stuart Cobbe; Roy Taylor; Robin Prescott; Robert Lee; Jean Bancroft; Shirley MacEwan; James Shepherd; Peter Macfarlane; Andrew Morris; Roland Jung; Christopher Kelly; Alan Connacher; Norman Peden; Andrew Jamieson; David Matthews; Graeme Leese; John McKnight; Iain O'Brien; Colin Semple; John Petrie; Derek Gordon; Stuart Pringle; Ron MacWalter
Journal:  BMJ       Date:  2008-10-16

9.  Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.

Authors:  Yang Hu; Frank B Hu; JoAnn E Manson
Journal:  J Am Heart Assoc       Date:  2019-09-30       Impact factor: 5.501

10.  Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index.

Authors:  Rohan Khera; Ambarish Pandey; Colby R Ayers; Mercedes R Carnethon; Philip Greenland; Chiadi E Ndumele; Vijay Nambi; Stephen L Seliger; Paulo H M Chaves; Monika M Safford; Mary Cushman; Vanessa Xanthakis; Ramachandran S Vasan; Robert J Mentz; Adolfo Correa; Donald M Lloyd-Jones; Jarett D Berry; James A de Lemos; Ian J Neeland
Journal:  JAMA Netw Open       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.